FDA Approves Inavolisib Breast Cancer Treatment

By Rene Pretorius

October 15, 2024

The FDA's approval of inavolisib breast cancer treatment in combination with palbociclib and fulvestrant is significant. It provides a new treatment option for a challenging patient population. This treatment is specifically for adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (H...
Eye Health Advancements and Ongoing Challenges in Africa
The article titled "Promising progress on eye health in the African region, but challenges remain" from the World Health Organization (WHO) Regional Office for Africa highlights several key points regarding the current state of eye health in the African region. While there has been notable progre...
Transforming Middle Eastern Healthcare through Digital Innovation
A recent article from The World Economic Forum emphasises the significant impact that digital innovation is having on the healthcare sector in Gulf Cooperation Council (GCC) countries. This digital innovation is changing healthcare by integrating advanced technologies such as artificial intellige...
Soaring Drug Prices in Europe: A Strain on Health Systems and Industry
A recent article from POLITICO Europe, titled "Drug prices in Europe are soaring — and are only expected to rise," highlights several key points regarding the rising drug prices in Europe, particularly in the context of the pharmaceutical industry and regulatory changes. Rising Drug Prices
EMA Competing Interests Policy for Scientific Committee Members

By João L. Carapinha

October 14, 2024

The European Medicines Agency (EMA) published a detailed revision of their policy on handling competing interests for scientific committee members and experts. This revision is essential, as it ensures that experts involved in the EMA's activities do not possess conflicts of interest that could u...
Enhancing Mental Health Care for Youth: A Critical Need
Introduction Mental health care for youth, particularly in early childhood, is a pressing issue. Recent studies reveal that one in five children aged 3 to 17 in the US has a mental disorder. The COVID-19 pandemic has further exacerbated these conditions, highlighting the urgent need for...

Search By Category

Join our newsletter

Latest

FDA Approves Inavolisib Breast Cancer Treatment

By Rene Pretorius

October 15, 2024

The FDA's approval of inavolisib breast cancer treatment in combination with palbociclib and fulvestrant is significant. It provides a new treatment option for a challenging patient population. This treatment is specifically for adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (H...

Latest

Eye Health Advancements and Ongoing Challenges in Africa
The article titled "Promising progress on eye health in the African region, but challenges remain" from the World Health Organization (WHO) Regional Office for Africa highlights several key points regarding the current state of eye health in the African region. While there has been notable progre...

Latest

Transforming Middle Eastern Healthcare through Digital Innovation
A recent article from The World Economic Forum emphasises the significant impact that digital innovation is having on the healthcare sector in Gulf Cooperation Council (GCC) countries. This digital innovation is changing healthcare by integrating advanced technologies such as artificial intellige...

Latest

Soaring Drug Prices in Europe: A Strain on Health Systems and Industry
A recent article from POLITICO Europe, titled "Drug prices in Europe are soaring — and are only expected to rise," highlights several key points regarding the rising drug prices in Europe, particularly in the context of the pharmaceutical industry and regulatory changes. Rising Drug Prices

Global Updates

FDA Approves Inavolisib Breast Cancer Treatment
The FDA's approval of inavolisib breast cancer treatment in combination with palbociclib and fulvestrant is significant. It provides a new treatment option for a challenging patient population. This treatment is specifically for adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (H...

Global Updates

Enhancing Mental Health Care for Youth: A Critical Need

By Danélia Botes

October 14, 2024

Introduction Mental health care for youth, particularly in early childhood, is a pressing issue. Recent studies reveal that one in five children aged 3 to 17 in the US has a mental disorder. The COVID-19 pandemic has further exacerbated these conditions, highlighting the urgent need for...

Global Updates

FDA’s Opdivo Lung Cancer Approval

By João L. Carapinha

October 11, 2024

The FDA has approved a new treatment regimen using Opdivo (nivolumab) for resectable non-small cell lung cancer (NSCLC), marking a significant advancement in cancer care. This approval paves the way for ...

Global Updates

Mental Healthcare for Youth: Addressing Substance Use and Chronic Conditions

By Danélia Botes

October 10, 2024

Introduction Chronic medical conditions (CMCs) in youths present unique challenges, particularly concerning substance use (SU). Defined as conditions persisting for over a year, CMCs require continuous medical attention and can limit daily activities. Youths with CMCs are often more pro...

Europe

rising drug prices Europe
           

Soaring Drug Prices in Europe: A Strain on Health Systems and Industry

💊 The rising cost of drugs in Europe is creating significant challenges for public health systems and insurance bodies. As highlighted in a recent POLITICO Europe article, the soaring prices, especially for cancer and rare disease medications, are straining budgets across various countries.

Explore the tension between regulatory changes aimed at controlling these costs and the pharmaceutical industry’s concerns about innovation and investment.

#SyenzaNews #DrugPricing #Pharmaceuticals

Middle East

digital healthcare innovation
        

Transforming Middle Eastern Healthcare through Digital Innovation

🚀 The future of healthcare in the Middle East is bright! Digital innovation is revolutionising the sector in GCC countries, leveraging AI, robotics, and telemedicine to enhance patient care and operational efficiency. With significant public-private collaborations and a thriving entrepreneurial ecosystem, the region is set to unlock billions in economic benefits while improving health outcomes.

Dive into our latest insights to discover how these advancements are shaping a new era in healthcare!

#SyenzaNews #DigitalHealth #Innovation #GCCCountries

Sub-Saharan Africa

eye health Africa
          

Eye Health Advancements and Ongoing Challenges in Africa

🌍 Promising progress on eye health in Africa is evident, yet significant challenges persist. The WHO highlights advancements such as the successful Onchocerciasis Control Programme and the integration of eye care into primary health services. However, resource shortages and low community awareness continue to hinder progress.

Explore how WHO initiatives like SPECS 2030 and the WHOeyes self-assessment tool aim to address these challenges and improve access to eye care.

#SyenzaNews #EyeHealth #HealthcareAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER




SERVICES

© 2024 Syenza™. All rights reserved.